Fig 1.
Proportion of death among 379 inpatients with Klebsiella pneumoniae bloodstream infections (KP BSIs) from 2018 to 2022 by antimicrobial resistance phenotypes.
ALL, All KP BSIs; MDR, multidrug resistant; non-MDR, non-multidrug resistant; CR, carbapenem resistant; non-CR, non-carbapenem resistant.
Fig 2.
Distribution of departments of 379 inpatients with Klebsiella pneumoniae bloodstream infections (KP BSIs) by antimicrobial resistance phenotypes.
ALL, all KP BSIs; MDR, multidrug resistant; CR, carbapenem resistant.
Table 1.
Risk factors for multidrug-resistant Klebsiella pneumoniae bloodstream infections (MDRKP BSIs).
Table 2.
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infections (CRKP BSIs).